Clinical trials
Suspended Sarcoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| DNAtrix, Inc. | 1 |
| Enzon Pharmaceuticals, Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
| University of Florida | 1 |
| University of Wisconsin, Madison | 1 |
| Washington University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 6 |
| Melanoma | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
| Carcinoma, Squamous Cell | 1 |
| Colorectal Neoplasms | 1 |
| Gastrointestinal Stromal Tumors | 1 |
| Neoplasm Metastasis | 1 |
| Rhabdomyosarcoma | 1 |
| Sarcoma, Ewing | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.